ID

22580

Description

Study ID: 100310 Clinical Study ID: RRL100310 Study Title: A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of intermittent dosing of ropinirole in patients with Restless Legs Syndrome (RLS) Part 27: Visit 4 (Week 7) RLS Episode 4 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00225862 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome More details on: https://clinicaltrials.gov/ct2/show/NCT00225862

Lien

https://clinicaltrials.gov/ct2/show/NCT00225862

Mots-clés

Versions (2)
  1. 08/06/2017 08/06/2017 -
  2. 12/06/2017 12/06/2017 -
Téléchargé le

8 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 27: Visit 4 (Week 7) RLS Episode 4

Anglais

Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 27: Visit 4 (Week 7) RLS Episode 4

1 Formulaires  
General Information
Description

General Information

Subject Identifier
Description

Subject Identifier

Type de données

text

PRN Subject Diary
Description

PRN Subject Diary

1. Enter the date and time your RLs symptoms started.
Description

Date

Type de données

datetime

2. How severe were your RLS symptoms at the time you took the dose of study medication?
Description

Severity of RLS episode

Type de données

text

3. Did your RLS symptoms disrupt your routine evening activity?
Description

Did your RLS symptoms disrupt your routine evening activity?

Type de données

boolean

4. How severe were your RLS symptoms 2 hours after taking the study medication?
Description

Severity two hours after medication

Type de données

text

5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
Description

Read the following and complete the questions when you wake up next morning.

Type de données

text

6. Overall, did your RLS symptoms affect your sleep last night?
Description

Sleep affected by RLS symptoms?

Type de données

boolean

If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
Description

Specification of RLS symptoms affecting sleep

Type de données

boolean

Study Medication
Description

Study Medication

Date study medication taken
Description

Date study medication taken

Type de données

date

Time study medication taken
Description

Time study medication taken

Type de données

time

Retour au début de la page

Similar models

Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 27: Visit 4 (Week 7) RLS Episode 4

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
General Information
Subject Identifier
Item
Subject Identifier
text
Item Group
PRN Subject Diary
Date
Item
1. Enter the date and time your RLs symptoms started.
datetime
Item
2. How severe were your RLS symptoms at the time you took the dose of study medication?
text
Severity of RLS episode
Code List
2. How severe were your RLS symptoms at the time you took the dose of study medication?
CL Item
mild (1)
CL Item
moderate (2)
CL Item
severe (3)
CL Item
very severe (4)
Did your RLS symptoms disrupt your routine evening activity?
Item
3. Did your RLS symptoms disrupt your routine evening activity?
boolean
Item
4. How severe were your RLS symptoms 2 hours after taking the study medication?
text
Severity two hours after medication
Code List
4. How severe were your RLS symptoms 2 hours after taking the study medication?
CL Item
I was asleep at 2 hours after taking the last dose  (1)
CL Item
None (2)
CL Item
Mild (3)
CL Item
Moderate (4)
CL Item
Severe (5)
CL Item
Very Severe (6)
Item
5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
text
Change in RLS symptoms after dosing the night before
Code List
5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
CL Item
Very much improved (Complete symptom relief) (1)
CL Item
Much improved (Good symptom relief) (2)
CL Item
Minimally improved (Some symptom relief) (3)
CL Item
No change (4)
CL Item
Minimally worse (Symptoms minimally worse) (5)
CL Item
Much worse (Symptoms much worse) (6)
CL Item
Very much worse (Symptoms very much worse) (7)
Sleep affected by RLS symptoms?
Item
6. Overall, did your RLS symptoms affect your sleep last night?
boolean
Specification of RLS symptoms affecting sleep
Item
If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
boolean
Item Group
Study Medication
Date study medication taken
Item
Date study medication taken
date
Time study medication taken
Item
Time study medication taken
time
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial